Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E. Zhang
Institution:
University of North Carolina at Chapel Hill
Observed institutions:
University of North Carolina at Chapel Hill,
Kaiser Permanente,
Kaiser Permanente San Diego Medical Center
OpenAlex ID:
A5079306026
8 Evolution of Treatment-emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials
2011
·
J.C. Sullivan
, S. De Meyer
, et al.
·
Journal of Hepatology
·
51
WS04.2 Improvement in inflammatory biomarkers in patients (pts) with cystic fibrosis (CF) homozygous for the F508del-CFTR mutation treated with lumacaftor (LUM) and ivacaftor (IVA)
2016
·
J.C. Sullivan
, F.J. Accurso
, et al.
·
Journal of Cystic Fibrosis
·
4
PDF
753 Role of therapies and healthcare systems to outcomes in CF in Canada and US
2025
·
M. Muhlebach
, J. She
, et al.
·
Journal of Cystic Fibrosis
P364 Emergent airway infections with chronic inhaled antibiotics
2025
·
M.S. Muhlebach
, E. Zhang
, et al.
·
Journal of Cystic Fibrosis
94 Trends of inhaled antibiotic prescription for non-chronic and chronic P. aeruginosa infection
2024
·
M. Muhlebach
, J. She
, et al.
·
Journal of Cystic Fibrosis
Show more works
View as search
Works count:
5
Citation count:
55
H-index:
2
I10-index:
1
Year
Topic
Type